Rigel Pharmaceuticals Aktie

Rigel Pharmaceuticals, Inc. (RIGL) Q4 2024 Earnings Call Transcript

Rigel Pharmaceuticals (RIGL) Surpasses Q4 Earnings and Revenue Estimates

Rigel (RIGL) delivered earnings and revenue surprises of 45.45% and 0.02%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead...

Should You Add RIGL Stock to Your Portfolio Pre-Q4 Earnings?

Rigel Pharmaceuticals has put up a strong performance in 2024 and should maintain momentum in 2025. Irrespective of how the company fares in Q4, we recommend investors to...

RIGL Stock Surges 41.4% in a Year: Time to Buy or Sell?

Rigel Pharmaceuticals has put up a strong performance in 2024 and should maintain momentum in 2025. We believe there is more room for growth.